21 October 2009 - Kinaxo Biotechnologies has entered into a collaboration with Roche Diagnostics in the field of phosphoproteomics.
Under the agreement, Kinaxo's Phosphoscout phosphoproteomics technology will be applied to support the identification of biomarkers related to new treatment approaches based upon therapeutic antibodies under development at Roche.
Financial details of the agreement were not disclosed.
